Please plan to join us for the first of our new monthly program focused on drug development topics and resources. This interactive series kickoff will be focused on the importance of the Target Product Profile (TPP) and considerations for its development for therapeutics projects. Speakers leading this discussion will include Brett Cornwell, Executive Director for Texas A&M Technology Commercialization and Philip Jones, VP, Therapeutics Discovery, MDA Cancer Center; and Head, Drug Discovery, Institute for Applied Cancer Science (IACS).

A networking reception will follow.